Headache

The Journal of Head and Face Pain

Official publication of the American Headache Society

Edited by: Thomas N. Ward, MD
2015 Impact Factor: 2.961
ISI Journal Citation Reports © Ranking 2015: 63/192 (Clinical Neurology)

Current Issue Highlights

Highlights from the November-December 2018 issue:

Reasons for Manuscript Rejection After Peer Review from the Journal Headache
Hesterman CM, Szperka CL, Turner DP

Essential Steps to Ensure Publication in Headache (and any other journal of good repute)
Roberts JL
This issue of Headache includes articles that provide insights into why manuscripts get rejected from Headache and steps that should be taken to improve the likelihood of acceptance. Although several shortcomings may result in rejection, flaws in methodology and study design are the most common. Thus, investigators should consider consulting with an expert in research methodology and statistics when planning their study.

Recommendations on the Use of Anti-CGRP Monoclonal Antibodies in Children and Adolescents
Szperka CL, VanderPluym J, Orr SL, et. al.
Although now approved for migraine treatment in adults, the potential efficacy and safety of CGRP monoclonal antibodies (mAbs) in children and adolescents is yet to be determined. To fill the gap until such data are available, members of the American Headache Society Pediatric and Adolescent special interest group provide their expert opinion on contraindications, possible indications, and monitoring during CGRP mAb treatment.

Early View

Illness Perception and Job Satisfaction in Patients Suffering from Migraine Headaches: Trait Anxiety and Depressive Symptoms as Potential Mediators
Published online on Dec 13, 2018

The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice
Published online on Dec 10, 2018

Migraine and Markers of Carotid Atherosclerosis in Middle‐Aged Women: A Cross‐Sectional Study
Published online on Dec 05, 2018

Podcasts

The Role of Melatonin in the Treatment of Headache Disorders

Dr. Amy Gelfand is a child neurologist, a UCNS certified pediatric headache specialist, and a member of the American Headache Society. She directs the Pediatric Headache Program at the University of California, San Francisco. Her research is on the ttreatment of pediatric headache disorders and she is currently researching whether melatonin is effective for migraine prevention in adolescents.

Listen to the podcast from the interview of Dr. Gelfand.

Listen to all Headache podcasts for Health Professionals

Virtual Issues

Virtual issues are collections of articles on a particular subject, published in Headache: The Journal of Head and Face Pain. They are selected by a guest editor to provide a rapid overview of the activity in a particular aspect of headache medicine.